DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma ARG Signature Prognosis & Treatment Promise in DLBCL May 30, 2024
FL (Follicular Lymphoma),Lymphoma,MZL (Marginal Zone Lymphoma) Efficacy and Safety of IRR Combo in Untreated FL and MZL May 30, 2024
FL (Follicular Lymphoma),Lymphoma,MZL (Marginal Zone Lymphoma) Evaluating Imaging for Indolent Cutaneous B-cell Lymphomas May 24, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma HBsAg Positive Linked to Worse DLBCL Prognosis May 15, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Managing CAR-T Failure: Chidamide & PD-1 Blockade in LBCL May 14, 2024
FL (Follicular Lymphoma),Lymphoma Loncastuximab & Rituximab Combo: Effective in Rel/Ref FL May 08, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Optimizing CAR-T Outcomes: Effective Bridging Strategies May 08, 2024
